Genome International - Crunchbase Company Profile & Funding

Overview

Genome International

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Genome International

CB Rank

631718

Genome International Corporation (GIC) is a research-driven firm.

Founded

obfuscation

Private

Madison, Wisconsin, United States

51-100

www.genome.com/

Biotechnology

Key People

Periannan Senapathy: Founder, CEO & Chief Scientific Officer

Details

Operating Status

Active

Company Type

For Profit

Founders

Periannan Senapathy

About the Company

Genome International Corporation (GIC) is a research-driven firm providing innovative bioinformatics products and custom research solutions for corporate, government, and academic laboratories in biomedical sciences. Their scientists and engineers are passionate about delivering high quality yet cost effective products and services by innovating

advances in bioinformatics and information technologies to optimize the management, analysis and mining of high-throughput molecular biology data.

Phone Number

+1 608-833-5855

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Genome Explorer

A genomic analysis and clinical decision support platform that analyzes whole genome data to generate clinical reports for healthcare providers.

Cancer Diagnosis and Therapeutics

A service that identifies somatic and germline mutations, gene fusions, CNVs, and structural variants in tumor DNA to generate clinical reports aligned with oncology guidelines.